Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,556.00    0.00 (0.00%)
Bid:
2,500.00
Ask:
2,750.00
Spread: 250.00 (10.00%)
Market Cap: £22.82b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Capital allocation update

30 Jan 2026 07:00

RNS Number : 9984Q
Experian plc
30 January 2026
 

 

news release

 

 

Capital allocation update: launch of US$1bn share repurchase programme

30 January 2026 - Experian, the global data and technology company, today announces the launch of a US$1bn share repurchase programme (the Programme).

We continue to trade strongly underpinned by our strategic execution and we expect to end this financial year in a favourable leverage position. This enables us to continue to invest in the business while also returning excess capital to shareholders.

 

Given this flexibility, we see opportunity to drive additional shareholder value through the introduction of increased share repurchases. Our medium-term financial framework, capital allocation framework and dividend policy are all unchanged.

 

The Experian plc Board has approved the following Programme:

 

· A share repurchase of up to US$1bn to conclude no later than 30 June 2027. The maximum number of shares that may be repurchased is 89,789,942 pursuant to the authority granted at the 2025 AGM.

· The pace and form of the proposed capital return will be subject to market conditions, and the ongoing assessment of the capital needs of the business. The purpose of the Programme is to reduce the number of shares in issue and to meet obligations arising from employee share plans of c.$200m.

· Experian has entered into an engagement with JP Morgan in connection with the first tranche of the Programme, to commence immediately.

 

This announcement contains Inside Information.

Company LEI: 635400RXXHHYT1JTSZ26.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGZMRLKGVZM
Date   Source Headline
16th Oct 20195:13 pmRNSTransaction in Own Shares
15th Oct 20195:13 pmRNSTransaction in Own Shares
14th Oct 20194:48 pmRNSTransaction in Own Shares
11th Oct 20194:55 pmRNSTransaction in Own Shares
7th Oct 201910:58 amRNSShare repurchase programme
4th Oct 20195:05 pmRNSTransaction in Own Shares
3rd Oct 20195:13 pmRNSTransaction in Own Shares
2nd Oct 20195:17 pmRNSTransaction in Own Shares
2nd Oct 20199:15 amRNSAdditional Listing
30th Sep 201912:26 pmRNSTotal Voting Rights
25th Sep 20195:10 pmRNSTransaction in Own Shares
20th Sep 20195:09 pmRNSTransaction in Own Shares
19th Sep 20194:55 pmRNSTransaction in Own Shares
19th Sep 201912:54 pmRNSBlock listing Interim Review
18th Sep 20194:52 pmRNSTransaction in Own Shares
17th Sep 20194:57 pmRNSTransaction in Own Shares
16th Sep 20195:03 pmRNSTransaction in Own Shares
13th Sep 20195:01 pmRNSTransaction in Own Shares
12th Sep 20195:20 pmRNSTransaction in Own Shares
11th Sep 20195:09 pmRNSTransaction in Own Shares
10th Sep 20195:10 pmRNSTransaction in Own Shares
30th Aug 201911:58 amRNSTotal Voting Rights
22nd Aug 20199:37 amRNSAdditional Listing
21st Aug 20198:00 amRNSExperian acquires Look Who's Charging
15th Aug 20195:09 pmRNSTransaction in Own Shares
8th Aug 201911:00 amRNSAcquisition of MyHealthDirect
6th Aug 20195:05 pmRNSTransaction in Own Shares
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.